Modelling the implications of reducing smoking prevalence: the public health and economic benefits of achieving a 'tobacco-free' UK

Tobacco Control
Daniel HuntMartin Brown

Abstract

Smoking is still the most preventable cause of cancer, and a leading cause of premature mortality and health inequalities in the UK. This study modelled the health and economic impacts of achieving a 'tobacco-free' ambition (TFA) where, by 2035, less than 5% of the population smoke tobacco across all socioeconomic groups. A non-linear multivariate regression model was fitted to cross-sectional smoking data to create projections to 2035. These projections were used to predict the future incidence and costs of 17 smoking-related diseases using a microsimulation approach. The health and economic impacts of achieving a TFA were evaluated against a predicted baseline scenario, where current smoking trends continue. If trends continue, the prevalence of smoking in the UK was projected to be 10% by 2035-well above a TFA. If this ambition were achieved by 2035, it could mean 97 300 +/- 5 300 new cases of smoking-related diseases are avoided by 2035 (tobacco-related cancers: 35 900+/- 4 100; chronic obstructive pulmonary disease: 29 000 +/- 2 700; stroke: 24 900 +/- 2 700; coronary heart disease: 7600 +/- 2 700), including around 12 350 diseases avoided in 2035 alone. The consequence of this health improvement is predicted to avoid £67 ...Continue Reading

References

Feb 7, 2001·American Journal of Public Health·G SorensenC Levenstein
Jan 15, 2003·The Journal of School Health·UNKNOWN Office on Smoking and Health, Division of Adolescent and School Health National Center for Chronic Disease Prevention and He
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Carole WilliJacques Cornuz
Jan 15, 2008·Cost Effectiveness and Resource Allocation : C/E·Rudolf T HoogenveenTalitha L Feenstra
Aug 30, 2008·Tobacco Control·E Avila-TangJ M Samet
Aug 26, 2010·Health Economics, Policy, and Law·Christine CallumAmanda Sandford
Oct 6, 2011·BMJ : British Medical Journal·Sanjay BasuStanton A Glantz
Dec 14, 2011·Journal of the National Cancer Institute·Vincent James CoglianoChristopher P Wild
Dec 14, 2011·British Journal of Cancer·D M Parkin
May 10, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·L WebberM Brown
Jul 25, 2012·European Journal of Public Health·David T LevyLuke Clancy
May 15, 2013·Lancet·Christopher J L MurrayAdrian Davis
Aug 22, 2013·BMJ : British Medical Journal·Robert WestAndy McEwen
Nov 2, 2014·BMJ : British Medical Journal·Mahiben MaruthappuBruce Keogh
Dec 10, 2014·Health Economics·Karl ClaxtonAnthony J Culyer
Dec 11, 2014·Tobacco Control·Jolene DubrayJoanna E Cohen
Mar 7, 2015·Nihon eiseigaku zasshi. Japanese journal of hygiene·Hiroshi YamatoMasanori Ohta
May 16, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Shari P FeirmanAndrea C Villanti
Sep 1, 2015·Tobacco Control·Patricia A McDanielRuth E Malone
Sep 20, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·David LevyYian Zhang
Dec 15, 2015·BMJ : British Medical Journal·Clare Dyer
Apr 2, 2016·Bulletin of the World Health Organization·Mark GoodchildNigar Nargis

❮ Previous
Next ❯

Citations

Feb 14, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·John HutchinsonUNKNOWN British Thoracic Society
Jun 24, 2020·Deutsche medizinische Wochenschrift·Reiner HanewinkelFriedrich J Wiebel
Aug 29, 2020·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Sanja StanojevicAnne L Stephenson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.